Hims & Hers Health (HIMS) Competitors $22.59 +1.95 (+9.45%) (As of 12:09 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends HIMS vs. NTRA, FMS, PACS, SHC, OPCH, SGRY, BTSG, GH, VCYT, and LFSTShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Fresenius Medical Care (FMS), PACS Group (PACS), Sotera Health (SHC), Option Care Health (OPCH), Surgery Partners (SGRY), BrightSpring Health Services (BTSG), Guardant Health (GH), Veracyte (VCYT), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Natera Fresenius Medical Care PACS Group Sotera Health Option Care Health Surgery Partners BrightSpring Health Services Guardant Health Veracyte LifeStance Health Group Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, community ranking, valuation, media sentiment, analyst recommendations and risk. Do analysts rate NTRA or HIMS? Natera currently has a consensus target price of $125.69, suggesting a potential upside of 0.86%. Hims & Hers Health has a consensus target price of $20.71, suggesting a potential downside of 13.87%. Given Natera's stronger consensus rating and higher probable upside, research analysts clearly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00Hims & Hers Health 0 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the MarketBeat Community believe in NTRA or HIMS? Natera received 436 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.56% of users gave Natera an outperform vote while only 36.84% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformNateraOutperform Votes47168.56% Underperform Votes21631.44% Hims & Hers HealthOutperform Votes3536.84% Underperform Votes6063.16% Which has higher valuation and earnings, NTRA or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.08B14.24-$434.80M-$2.45-50.87Hims & Hers Health$872M5.92-$23.55M$0.08300.66 Does the media favor NTRA or HIMS? In the previous week, Hims & Hers Health had 34 more articles in the media than Natera. MarketBeat recorded 51 mentions for Hims & Hers Health and 17 mentions for Natera. Hims & Hers Health's average media sentiment score of 0.66 beat Natera's score of 0.15 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 5 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hims & Hers Health 15 Very Positive mention(s) 7 Positive mention(s) 13 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in NTRA or HIMS? 99.9% of Natera shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 7.6% of Natera shares are owned by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is NTRA or HIMS more profitable? Hims & Hers Health has a net margin of 1.70% compared to Natera's net margin of -21.47%. Hims & Hers Health's return on equity of 5.25% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-21.47% -36.74% -19.90% Hims & Hers Health 1.70%5.25%4.06% Which has more risk and volatility, NTRA or HIMS? Natera has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500. SummaryNatera and Hims & Hers Health tied by winning 9 of the 18 factors compared between the two stocks. Ad Huge AlertsNASDAQ small cap that could be gearing up for a massive short squeeze.There is a NASDAQ Listed stock that has an INSANE Short position. It’s over 22 Million Shares short and the cost to borrow is over 140%!!! We are issuing an alert at the open tomorrow!!!Sign up now! To get this alert sent to you minutes before the open! Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE ExchangeMarket Cap$5.17B$965.56M$5.26B$19.69BDividend YieldN/AN/A5.07%3.56%P/E Ratio300.6659.41124.5940.64Price / Sales5.921.411,566.7414.37Price / CashN/A43.3134.4517.31Price / Book14.947.654.735.35Net Income-$23.55M-$52.07M$117.50M$987.96M7 Day Performance26.18%5.10%2.17%2.13%1 Month Performance36.18%3.97%8.13%1.78%1 Year Performance283.57%4.47%38.20%27.72% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health3.0132 of 5 stars$22.59+9.4%$20.71-8.3%+218.5%$4.85B$872M282.411,046Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap UpHigh Trading VolumeNTRANatera2.8932 of 5 stars$124.16+2.6%N/A+191.0%$15.36B$1.08B-50.683,293Upcoming EarningsAnalyst UpgradeFMSFresenius Medical Care4.0502 of 5 stars$19.76+1.1%N/A+16.6%$11.60B$19.42B20.371,358Analyst ForecastNews CoveragePositive NewsGap UpPACSPACS Group4.1287 of 5 stars$42.94+0.6%N/AN/A$6.54B$3.11B0.0032,433Upcoming EarningsAnalyst ForecastNews CoverageGap DownSHCSotera Health3.06 of 5 stars$15.86+1.2%N/A+16.7%$4.49B$1.05B113.293,000Earnings ReportNews CoverageOPCHOption Care Health4.9299 of 5 stars$24.11+4.6%N/A-21.9%$4.12B$4.30B20.267,802Analyst DowngradeAnalyst RevisionGap UpHigh Trading VolumeSGRYSurgery Partners2.5786 of 5 stars$28.75-0.2%N/A+19.4%$3.65B$2.89B-106.4813,500Upcoming EarningsAnalyst ForecastNews CoverageBTSGBrightSpring Health Services2.0532 of 5 stars$17.25+15.2%N/AN/A$2.96B$8.83B0.0035,000Earnings ReportAnalyst ForecastAnalyst RevisionGap UpHigh Trading VolumeGHGuardant Health4.6297 of 5 stars$23.00+5.1%N/A-18.0%$2.69B$643.81M-5.621,779Gap UpVCYTVeracyte4.3992 of 5 stars$34.31+1.7%N/A+46.9%$2.64B$399.58M-45.75790Gap UpLFSTLifeStance Health Group0.8776 of 5 stars$6.81+1.5%N/A+12.3%$2.61B$1.06B-16.619,325Upcoming Earnings Related Companies and Tools Related Companies NTRA Competitors FMS Competitors PACS Competitors SHC Competitors OPCH Competitors SGRY Competitors BTSG Competitors GH Competitors VCYT Competitors LFST Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:HIMS) was last updated on 11/6/2024 by MarketBeat.com Staff From Our PartnersTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredCharles Payne Wants You Prepared for Q4Charles Payne Wants You Prepared for Q4 Because as we look toward 2025, there's no denying that market vola...Unstoppable Prosperity | SponsoredNASDAQ small cap that could be gearing up for a massive short squeeze.A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!Huge Alerts | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
